Skip to main content
. 2010 Nov;99(11):1695–1700. doi: 10.1111/j.1651-2227.2010.01896.x

Table 1.

Baseline characteristics in the intention-to-treat group (Mean ± standard deviation)

EF group SF group All infants



n 422 349 771
Age at enrolment (day) 153 ± 44 151 ± 34 152 ± 40
Weight at enrolment (kg) 6.96 ± 1.02 6.98 ± 0.90 6.97 ± 0.96
Length at enrolment (cm) 64.0 ± 3.7 64.2 ± 3.8 64.1 ± 3.81
Family history of allergy (%) 38.4* 27.0 33.2
Personal history of allergy (%) 16.1* 10.0 13.3
Number of siblings (n) 0.69 ± 0.84 0.60 ± 0.85 0.66 ± 0.84
Frequent infectious episodes in parents (%) 7.7 5.2 6.5
Smoking in the family home (%) 15.4 17.9 16.5
Number of infectious diseases since birth (n) 1.0 ± 1.3* 0.7 ± 1.2 0.9 ± 1.2
Partly or exclusively breast feeding at inclusion (%) 47.2 45.5 46.4
Consumption of prebiotic- or probiotic-enriched infant formula before inclusion (%) 20.6 15.4 18.3
Dietary diversification before inclusion (%) 85.0 87.4 86.1
Daily volume of follow-on formula prescribed (mL) 748 ± 180 752 ± 176 750 ± 178
Addition of wheat to follow-on formula (%) 27.8 28.4 28.1
*

p < 0.05 versus SF (Student's t-test or χ2/Fisher's exact test).